Determinants of End-of-life Place of Care for Children Suffering From Cancer.
NCT02060578 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2015-12-18
Summary
Cancer is the second cause of over-one-year-old children mortality after accident. Survival rate is more than 70%, but in some cases, curative treatments are not sufficient and palliative support is implemented for those children in end of life.
Pediatric guidelines about the place of end-of-life care are varied. On European scale, home is recommended (IMPaCCT study, 2007). In France, the 2008-2012 palliative care development program recommended home or initial hospital care unit. This program also supports implementation of mobile team rather than specific hospital units.
In Brittany, a pattern of regional palliative care resource team has been implemented since 2005. In oncology, further to the guidelines, end-of-life place of care is often discussed several times for each case. Sometimes occur a lot of returns between home and hospital, psychological difficulties, and difficulties to offer adapted care conditions. Finally, less than 30% of children in palliative care decease at home.
The primary objective is to identify main determinants of the place of palliative care in pediatric oncology.
The secondary objective is to clarify the factors of change comparing to the initial planned place.
Intervention :
Questionnaire completed by the parents Interview with the parents and the psychologist (University Rennes 2)
Number of subjects is : Parents of 68 to 93 children who died from cancer after a palliative phase, that means 136 to 186 parents.
Expected results and perspectives :
Using both quantitative and qualitative methods, expected results are the followings:
* Identification of the objective and subjective factors, which influenced the decision of the place of care.
* Determination of the factors of change comparing to the initial planned place.
Once identified, main factors could be the ones to pay attention to in order to help for initial decision, better anticipation of change of place and better guidance of palliative care organization wherever, at home or in hospital.
Results would be new information for research on palliative care for children but also for adults.
Finally, this work is part of an improving approach of palliative care, related to the development of open-care hospital networks. We can expect some public health impacts with new arguments to help for complementary recommendations.
Conditions
Interventions
- OTHER
-
Questionnaire and interview
Questionnaire completed by the parents Interview with the parents and the psychologist (University Rennes 2)
Sponsors & Collaborators
-
University of Rennes 2
collaborator OTHER -
Rennes University Hospital
lead OTHER
Principal Investigators
-
Guillaume Robert · Rennes University Hospital
Study Design
- Allocation
- NA
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2015-07-31
- Completion
- 2015-07-31
Countries
- France
Study Locations
More Related Trials
-
The PediQUEST Response Intervention Study
NCT03408314 ·Status: COMPLETED ·Phase: NA
-
Neurocognitive Risks in Children With Solid Tumors
NCT03609112 ·Status: RECRUITING
-
Exploring The Role Of Palliative Care In Phase 1 Enrolled Pediatric Oncology Patients
NCT05412563 ·Status: TERMINATED
-
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
NCT00002485 ·Status: COMPLETED
-
Analyse of Tumour and Constitutional DNA for the Study of the Determinism in Child Neoplasia
NCT04471961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Validation Study of Pediatric Patient-Reported Outcomes
NCT03229837 ·Status: COMPLETED
-
Preventing Cardiac Sequelae in Pediatric Cancer Survivors
NCT01805778 ·Status: COMPLETED
-
Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma
NCT00418327 ·Status: COMPLETED ·Phase: PHASE1
-
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
NCT02847130 ·Status: COMPLETED
-
Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas
NCT01574092 ·Status: COMPLETED ·Phase: PHASE2
-
PCRC-Supported Legacy Intervention in Pediatric Palliative Care
NCT04059393 ·Status: COMPLETED ·Phase: NA
-
Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
NCT04477681 ·Status: RECRUITING
-
DCV in the Treatment of Recurrence and Refractory Childhood Solid Tumors
NCT04213612 ·Status: UNKNOWN ·Phase: PHASE1
-
Home Chemotherapy Intervention for Children With Cancer - a Feasibility Study
NCT05372536 ·Status: COMPLETED ·Phase: NA
-
LIFE Cancer Survivorship Database for Pediatric Cancer
NCT01518400 ·Status: RECRUITING
-
Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL
NCT04168788 ·Status: UNKNOWN ·Phase: NA
-
Cancer Therapy-related Cardiac Dysfunction Occuring in Children Treated by Anticancer Drugs for Malignancies
NCT05602103 ·Status: NOT_YET_RECRUITING
-
Radiation Therapy and the Natural History of Childhood Cancers
NCT00064883 ·Status: COMPLETED
-
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer
NCT01802567 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
NCT00213278 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy
NCT00001387 ·Status: COMPLETED ·Phase: PHASE1
-
Mobile Health Case Management System for Reducing Pediatric Treatment Abandonment
NCT03677128 ·Status: COMPLETED ·Phase: NA
-
A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
NCT02256137 ·Status: ACTIVE_NOT_RECRUITING
-
Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma
NCT00024193 ·Status: UNKNOWN ·Phase: PHASE2
-
Protocol For Collecting Data On Patients With Childhood Cancer
NCT00684580 ·Status: RECRUITING